A recent non-immunosuppressive cell-impermeable cyclophilin inhibitor, MM284, reduced the myocardial injury and fibrosis in a mouse model of troponin I-induced autoimmune myocarditis [19]. This evidence concerns the gene PPIB and autoimmune myocarditis.